Editorial Board
Journal of ImmunoTherapy of Cancer Editorial Board members have agreed and adhere to the BMJ Editor Roles and Responsibilities guidelines; including our Editor policy on competing interests.
Editor-in-Chief
Michael T. Lotze, MD
University of Pittsburgh, United States
Declaration of Interests
Deputy Editor-in-Chief
Sjoerd H. van der Burg, PhD
Oncode Institute & Leiden University Medical Center, Netherlands
Declaration of Interests
Outgoing Editor-in-Chief
James L. Gulley, MD, PhD, FACP
National Cancer Institute, National Institutes of Health, United States
Declaration of Interests
Basic Tumor Immunology
Section Editor
Claudia Palena, PhD
National Cancer Institute, National Institutes of Health, United States
Eric Tartour, MD, PhD
Hôpital Européen Georges Pompidou, France
Associate Editors
Scott I. Abrams, PhD
Roswell Park Comprehensive Cancer Center, United States
Timothy NJ Bullock, PhD*
University of Virginia, United States
orcid.org/0000-0001-6141-3261
Gennaro Ciliberto, MD
IRCCS Istituto Nazionale Tumori Regina Elena, Italy
orcid.org/0000-0003-2851-8605
Khashayarsha Khazaie, PhD, DSc
Mayo Clinic College of Medicine, United States
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
Michael Platten, MD
Ruprecht-Karls University Heidelberg, Germany
orcid.org/0000-0002-4746-887X
Stefani Spranger, PhD
Massachusetts Institute of Technology, United States
Walter J. Storkus, PhD
University of Pittsburgh, United States
Viktor Umansky, PhD
German Cancer Research Center (DKFZ), Germany
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
Case Reports
Section Editor
Sebastian Kobold, MD
Klinikum der Universität München, Germany
Associate Editors
Jack D. Bui, MD, PhD
University of California San Diego, United States
orcid.org/0000-0002-9324-368X
Marco Donia, MD, PhD
National Center for Cancer Immune Therapy, Denmark
orcid.org/0000-0003-4966-9752
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
Heinz Läubli, MD, PhD
University Hospital Basel, Switzerland
orcid.org/0000-0002-8910-5620
Allison Betof Warner, MD, PhD
Stanford Cancer Center, United States
Clinical/Translational Cancer Immunotherapy
Section Editors
Jason J. Luke, MD, FACP
University of Pittsburgh Medical Center, United States
orcid.org/0000-0002-1182-4908
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
Douglas G. McNeel, MD, PhD
University of Wisconsin Carbone Cancer Center, United States
orcid.org/0000-0003-1471-6723
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
Associate Editors
Paolo Antonio Ascierto, MD
Istituto Nazional Tumori-Fondazione ‘G.Pascale’, Italy
orcid.org/0000-0002-8322-475X
Richard D. Carvajal, MD
Northwell Health Cancer Institute, United States
Tina Cascone, MD, PhD
The University of Texas MD Anderson Cancer Center, United States
Tanja D. de Gruijl, PhD
Amsterdam University Medical Centers, the Netherlands
orcid.org/0000-0003-1464-8978
Brian R. Gastman, MD
Iovance Biotherapeutics, Inc., United States
Margaret E. Gatti-Mays, MD, MPH
Ohio State University Comprehensive Cancer Center, United States
orcid.org/0000-0001-8914-2897
Francois Ghiringhelli, PhD
Institut National De La Sante Et De Le Recherche Medicale (INSERM), France
James J. Harding, MD
Memorial Sloan Kettering Cancer Center, United States
Hongbo Hu, PhD
West China Hospital, Sichuan University, China
Douglas B. Johnson, MD, MSCI*
Vanderbilt University Medical Center, United States
Pawel Kalinski, MD, PhD*
Roswell Park Comprehensive Cancer Center, United States
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
Yangqiu Li, MD
Jinan University School of Medicine, China
Ravi A. Madan, MD
National Cancer Institute, National Institutes of Health, United States
orcid.org/0000-0001-5106-8636
Luca Mazzarella, MD, PhD
European Institute of Oncology, Italy
orcid.org/0000-0002-4043-3279
Sattva S. Neelapu, MD
The University of Texas MD Anderson Cancer Center, United States
Anna Obenauf, PhD
Research Institute of Molecular Pathology, Austria
Kunle Odunsi, MD, PhD
University of Chicago Medicine Comprehensive Cancer Center, United States
Ravi Patel, MD, PhD
University of Pittsburgh, United States
orcid.org/0000-0002-8328-746X
Alessandro Russo, MD, PhD
Università degli Studi di Messina, Italy
Louis M. Weiner, MD
Georgetown-Lombardi Comprehensive Cancer Center, United States
orcid.org/0000-0001-5192-0710
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
Commentary/Editorials
Section Editor
Christian M. Capitini, MD
University of Wisconsin, Madison, United States
orcid.org/0000-0002-2276-6731
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
Associate Editors
Ana Carrizosa Anderson, MD
Harvard University, United States
orcid.org/0000-0002-0877-2932
Diwakar Davar, MD
UPMC Hillman Cancer Center, United States
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
William J. Murphy, PhD
University of California, Davis, United States
orcid.org/0000-0002-2793-401X
Gabriel Rabinovich, PhD
Instituto de Biologia y Medicina Experimental (IByME), Argentina
orcid.org/0000-0002-0947-8735
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
Guidelines and Consensus Statements
Section Editor
Robert L. Ferris, MD, PhD
University of Pittsburgh Cancer Institute, United States
orcid.org/0000-0001-6605-2071
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
Immune Cell Therapies and Immune Cell Engineering
Section Editor
Marcela V. Maus, MD, PhD
Massachusetts General Hospital, United States
Deputy Editor
Aude Chapuis, MD
Fred Hutchinson Cancer Research Center, United States
Associate Editors
Marco L. Davila, MD, PhD*
Roswell Park Comprehensive Cancer Center, United States
orcid.org/0000-0002-6270-3065
Joseph A. Fraietta, PhD
University of Pennsylvania, United States
orcid.org/0000-0001-7900-8993
Sara Ghorashian, MD, PhD
University College London, United Kingdom
orcid.org/0000-0002-1555-2946
Jennifer L. Guerriero, PhD
Brigham and Women’s Hospital, United States
orcid.org/0000-0002-2104-5457
Michael Hudecek, MD
Universitätsklinikum Würzburg, Germany
Gerald Linette, MD, PhD
University of Pennsylvania, United States
orcid.org/0000-0001-6147-6115
Daniel J. Powell, Jr., PhD
University of Pennsylvania, United States
orcid.org/0000-0002-5966-8908
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
Marco Ruella, MD
University of Pennsylvania, United States
orcid.org/0000-0003-4301-5811
Lillian Seu, PhD
Revolution Medicines, United States
orcid.org/0000-0002-8456-019X
Nirali N. Shah, MD, MHSc
National Cancer Institute, National Institutes of Health, United States
orcid.org/0000-0002-8474-9080
Eric L. Smith, MD, PhD
Dana-Farber Cancer Institute, United States
orcid.org/0000-0002-0296-7587
Maria Themeli, MD, PhD
VUmc Cancer Center Amsterdam, the Netherlands
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
Immunotherapy Biomarkers
Section Editor
Ignacio Melero, MD, PhD
University of Navarra, Spain
orcid.org/0000-0002-1360-348X
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
Alexandra Snyder Charen, MD
Generate Biomedicines, United States
orcid.org/0000-0002-2606-3523
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
Deputy Editor
Kurt Schalper, MD, PhD
Yale School of Medicine, United States
Associate Editors
Valsamo Anagnostou, MD, PhD
Johns Hopkins University, United States
Maria Ascierto, PhD
AstraZeneca, United States
Carlo B. Bifulco, MD
Providence Portland Medical Center, United States
John C. Castle, PhD
Monte Rosa Therapeutics, Switzerland
orcid.org/0000-0001-8697-8955
Alessandra Cesano, MD, PhD*
ESSA Pharma Inc., United States
Eric Deutsch, MD, PhD
Gustave Roussy Cancer Campus, France
Jolanda de Vries, PhD
Radboud University Nijmegen, the Netherlands
Elisabeth G.E. de Vries, MD, PhD
University Medical Centre Groningen, the Netherlands
Michael D. Kalos, PhD*
CTRL Therapeutics, United States
Rejean Lapointe, PhD
Universite De Montreal, University Hospital (CRCHUM), Canada
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
Christian H. Ottensmeier, MD, PhD, FRCP
University of Liverpool, United Kingdom
Graham P. Pawelec, PhD
University of Tuebingen, Germany
orcid.org/0000-0002-3600-0163
Licia Rivoltini, MD
Fondazione IRCCS Istituto Nazionale Tumori, Italy
Barbara Seliger, MD, PhD
Martin Luther University Halle-Wittenberg, Germany
orcid.org/0000-0002-5544-4958
Craig L. Slingluff Jr., MD
University of Virginia, United States
orcid.org/0000-0002-6664-4373
Claudio Tripodo, MD
University of Palermo, Italy
orcid.org/0000-0002-0821-6231
Jianda Yuan, MD, PhD
Merck & Co., United States
orcid.org/0000-0003-3551-4434
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
Oncolytic and Local Immunotherapy
Section Editor
Howard L. Kaufman, MD, FACS
Massachusetts General Hospital, United States
orcid.org/0000-0003-1131-004X
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
Associate Editors
John C. Bell, PhD
Ottawa Hospital Research Institute, Canada
orcid.org/0000-0002-9083-357X
Kevin Harrington, PhD, FRCP, FRCR
The Institute of Cancer Research, United Kingdom
orcid.org/0000-0002-6014-348X
Samuel Rabkin, PhD*
Massachusetts General Hospital, United States
orcid.org/0000-0003-2344-2795
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
K. Dane Wittrup, PhD
Massachusetts Institute of Technology, United States
Dmitriy Zamarin, MD, PhD
Icahn School of Medicine at Mount Sinai, United States
orcid.org/0000-0002-0094-0161
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
Reviews
Section Editors
Sandra Demaria, MD
Weill Cornell Medical College, United States
orcid.org/0000-0003-4426-0499
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
Lawrence Fong, MD
University of California, San Francisco, United States
Associate Editors
Michael B. Atkins, MD
Georgetown-Lombardi Comprehensive Cancer Center, United States
orcid.org/0000-0003-3901-9924
Ira Mellman, PhD
Genentech, United States
orcid.org/0000-0002-6132-7299
James J. Mule, PhD
H. Lee Moffitt Cancer Center & Research Institute, United States
orcid.org/0000-0001-7354-0516
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
Specialty Editors
Consulting Editor, Special Series and Reviews
Pedro J. Romero, MD†
Novigenix, Switzerland
Consulting Editor
Thomas F. Gajewski, MD, PhD
University of Chicago, United States
Social Media Editors
Kristin G. Anderson, PhD
University of Virginia, United States
Praveen Bommareddy, PhD, MS
Replimune, Inc., United States
Cheng Sun, MD, PhD
University of Science and Technology of China, China
†Founding Editor-in-Chief (2013-2023)
*Consulting Reviews Editor
Publishing Team
Publisher: Shannon Lewis
Head of Portfolio: Kathleen Lyons